Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Spectrawave has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Spectrawave's investors include Lumira Ventures, S3 Ventures, Deerfield Management, SV Health Investors, Deerfield.
Spectrawave is headquartered in Waltham, United States.
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Spectrawave is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spectrawave — Funding & Investors." VCBacked, September 11, 2024, https://www.vcbacked.co/company/spectrawave. Accessed August 14, 2026.
VCBacked. (2024). Spectrawave — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/spectrawave
{{cite web |title=Spectrawave — Funding & Investors |url=https://www.vcbacked.co/company/spectrawave |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated